Iris Dx, Inc. is a Michigan-based biotech company. Our goal is to enhance and contribute to the field of Extracellular Vesicles. We are focused on providing a broad range of exosomes products and services leveraging our decades of experience in EV research and development. We have developed a pipeline of Exosomes-based diagnostics to improve early detection, treatment response, treatment monitoring and disease progression utilizing liquid based biopsy.
Our mission to enhance and improve the field of EV research and development hinges on our ability to facilitate customer research and accelerate external pipeline development for both diagnostics and therapeutics
We believe in strong partnerships and collaboration. Join our growing numbers of partners